Search research articles
Contact Us
Filters
Showing results (1471-1480 of 1,486) with videos related to
Page
of 149
Sort By:
Blood
|
November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
Hsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Annals of Hematology
|
September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
Hsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.
Journal of Medicinal Chemistry
|
October 30, 2024
DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration
Shu-Yu Lin, Yung-Chiao Chang, Ya-Wen Tien, et al.
Mayo Clinic Proceedings
|
June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
Ayalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Blood
|
August 11, 2011
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
Wen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, et al.
Emerging Infectious Diseases
|
April 14, 2004
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan
Po-Ren Hsueh, Lee-Jene Teng, Sung-Pin Tseng, et al.
Bone Marrow Transplantation
|
October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
Feng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
Molecular Cancer Research : MCR
|
May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease
Masaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Nature Communications
|
May 15, 2026
Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan
Yen-Po Yeh, Abbie Ting-Yu Lin, Wei-Wen Su, et al.
International Journal of Hematology
|
February 25, 2022
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan
Wen-Li Hwang, Tsung-Chih Chen, Hsuan-Yu Lin, et al.
Page
of 149
Search research articles
Search
Showing results (1471-1480 of 1,486) with videos related to
Sort By:
Page
of 149
Blood
|
November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
Hsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Annals of Hematology
|
September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
Hsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.
Journal of Medicinal Chemistry
|
October 30, 2024
DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration
Shu-Yu Lin, Yung-Chiao Chang, Ya-Wen Tien, et al.
Mayo Clinic Proceedings
|
June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
Ayalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Blood
|
August 11, 2011
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
Wen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, et al.
Emerging Infectious Diseases
|
April 14, 2004
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan
Po-Ren Hsueh, Lee-Jene Teng, Sung-Pin Tseng, et al.
Bone Marrow Transplantation
|
October 21, 2021
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
Feng-Ming Tien, Cheng-Hong Tsai, Sheng-Chuan Huang, et al.
Molecular Cancer Research : MCR
|
May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease
Masaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Nature Communications
|
May 15, 2026
Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan
Yen-Po Yeh, Abbie Ting-Yu Lin, Wei-Wen Su, et al.
International Journal of Hematology
|
February 25, 2022
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan
Wen-Li Hwang, Tsung-Chih Chen, Hsuan-Yu Lin, et al.
Page
of 149